Using publicly available databases, we show that both ATM mutation and ATM deficiency (diploid versus amplified) are associated with olaparib sensitivity in a panel of human lung adenocarcinoma cell lines (Fig. 1). This evidence concerns the gene ATM and lung adenocarcinoma.